These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 19208562

  • 1. Dendritic cells contribute to autoimmune kidney injury in MRL-Faslpr mice.
    Iwata Y, Furuichi K, Sakai N, Yamauchi H, Shinozaki Y, Zhou H, Kurokawa Y, Toyama T, Kitajima S, Okumura T, Yamada S, Maruyama I, Matsushima K, Kaneko S, Wada T.
    J Rheumatol; 2009 Feb; 36(2):306-14. PubMed ID: 19208562
    [Abstract] [Full Text] [Related]

  • 2. p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice.
    Iwata Y, Wada T, Furuichi K, Sakai N, Matsushima K, Yokoyama H, Kobayashi K.
    J Am Soc Nephrol; 2003 Jan; 14(1):57-67. PubMed ID: 12506138
    [Abstract] [Full Text] [Related]

  • 3. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR.
    J Immunol; 1998 Jul 01; 161(1):494-503. PubMed ID: 9647261
    [Abstract] [Full Text] [Related]

  • 4. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A.
    Arthritis Rheum; 2002 Nov 01; 46(11):3083-95. PubMed ID: 12428253
    [Abstract] [Full Text] [Related]

  • 5. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K.
    J Am Soc Nephrol; 2005 Sep 01; 16(9):2690-701. PubMed ID: 15987752
    [Abstract] [Full Text] [Related]

  • 6. Effects of cyclophilin A on myeloblastic cell line KG-1 derived dendritic like cells (DLC) through p38 MAP kinase activation.
    Bharadwaj U, Zhang R, Yang H, Li M, Doan LX, Chen C, Yao Q.
    J Surg Res; 2005 Jul 01; 127(1):29-38. PubMed ID: 15964302
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model.
    Sugiyama N, Kohno M, Yokoyama T.
    Nephrol Dial Transplant; 2012 Apr 01; 27(4):1351-8. PubMed ID: 22076433
    [Abstract] [Full Text] [Related]

  • 8. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy.
    Nishida M, Okumura Y, Sato H, Hamaoka K.
    Nephrol Dial Transplant; 2008 Aug 01; 23(8):2520-4. PubMed ID: 18515792
    [Abstract] [Full Text] [Related]

  • 9. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
    Zwerina J, Hayer S, Redlich K, Bobacz K, Kollias G, Smolen JS, Schett G.
    Arthritis Rheum; 2006 Feb 01; 54(2):463-72. PubMed ID: 16447221
    [Abstract] [Full Text] [Related]

  • 10. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT, Madaio MP, Shlomchik MJ.
    J Immunol; 1999 Oct 01; 163(7):3592-6. PubMed ID: 10490951
    [Abstract] [Full Text] [Related]

  • 11. Characterization of early events involved in human dendritic cell maturation induced by sensitizers: cross talk between MAPK signalling pathways.
    Trompezinski S, Migdal C, Tailhardat M, Le Varlet B, Courtellemont P, Haftek M, Serres M.
    Toxicol Appl Pharmacol; 2008 Aug 01; 230(3):397-406. PubMed ID: 18495191
    [Abstract] [Full Text] [Related]

  • 12. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
    Hamar P, Wang M, Godo M, Kokeny G, Rosivall L, Ouyang N, Heemann U.
    Lupus; 2010 Feb 01; 19(2):175-81. PubMed ID: 19946036
    [Abstract] [Full Text] [Related]

  • 13. Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains.
    Ma L, Chan KW, Trendell-Smith NJ, Wu A, Tian L, Lam AC, Chan AK, Lo CK, Chik S, Ko KH, To CK, Kam SK, Li XS, Yang CH, Leung SY, Ng MH, Stott DI, MacPherson GG, Huang FP.
    Eur J Immunol; 2005 Nov 01; 35(11):3364-75. PubMed ID: 16224814
    [Abstract] [Full Text] [Related]

  • 14. Effects of adding P38 mitogen-activated protein-kinase inhibitor to celsior solution in canine heart transplantation from non-heart-beating donors.
    Koike N, Takeyoshi I, Ohki S, Tokumine M, Matsumoto K, Morishita Y.
    Transplantation; 2004 Jan 27; 77(2):286-92. PubMed ID: 14742995
    [Abstract] [Full Text] [Related]

  • 15. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M, Hasegawa H, Kohno M, Inoue A, Miyazaki T, Terada M, Nose M, Yasukawa M.
    Arthritis Rheum; 2006 Nov 27; 54(11):3591-600. PubMed ID: 17075801
    [Abstract] [Full Text] [Related]

  • 16. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
    Hill RJ, Dabbagh K, Phippard D, Li C, Suttmann RT, Welch M, Papp E, Song KW, Chang KC, Leaffer D, Kim YN, Roberts RT, Zabka TS, Aud D, Dal Porto J, Manning AM, Peng SL, Goldstein DM, Wong BR.
    J Pharmacol Exp Ther; 2008 Dec 27; 327(3):610-9. PubMed ID: 18776065
    [Abstract] [Full Text] [Related]

  • 17. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
    Schwarting A, Paul K, Tschirner S, Menke J, Hansen T, Brenner W, Kelley VR, Relle M, Galle PR.
    J Am Soc Nephrol; 2005 Nov 27; 16(11):3264-72. PubMed ID: 16221871
    [Abstract] [Full Text] [Related]

  • 18. Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRL(lpr/lpr) mice.
    Sasaki S, Nagai Y, Yanagibashi T, Watanabe Y, Ikutani M, Kariyone A, Tsuneyama K, Hirai Y, Takatsu K.
    Mol Immunol; 2012 Jan 27; 49(4):611-20. PubMed ID: 22118968
    [Abstract] [Full Text] [Related]

  • 19. Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma.
    Zhao F, Falk C, Osen W, Kato M, Schadendorf D, Umansky V.
    Clin Cancer Res; 2009 Jul 01; 15(13):4382-90. PubMed ID: 19549770
    [Abstract] [Full Text] [Related]

  • 20. The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus.
    Jin N, Wang Q, Zhang X, Jiang D, Cheng H, Zhu K.
    Int Immunopharmacol; 2011 Sep 01; 11(9):1319-26. PubMed ID: 21549858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.